His win rate puts Warren Buffett to shame…

Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.

Craig Overpeck Biography and Net Worth

Insider of Doximity

Craig has over 25 years of experience delivering digital solutions that connect and serve physicians. Prior to joining Doximity in 2023, Craig served as the U.S. chief operating officer at M3 for over a decade and built MDLinx, which was acquired by M3 and became a critical part of the company’s U.S. business.

During his tenure at M3, he built the largest global market research offering, M3 Global Research, which connected the company’s physician communities across Asia, Europe, and North America. He received his B.S. from Ursinus College.

What is Craig Overpeck's net worth?: The estimated net worth of Craig Overpeck is at least $2.85 million as of October 16th, 2023. Mr. Overpeck owns 119,741 shares of Doximity stock worth more than $2,852,231 as of April 28th. This net worth approximation does not reflect any other investments that Mr. Overpeck may own. Learn More about Craig Overpeck's net worth.
How do I contact Craig Overpeck?: The corporate mailing address for Mr. Overpeck and other Doximity executives is , , . Doximity can also be reached via phone at 650-549-4330 and via email at [email protected]. Learn More on Craig Overpeck's contact information.
Has Craig Overpeck been buying or selling shares of Doximity?: Craig Overpeck has not been actively trading shares of Doximity within the last three months. Most recently, Craig Overpeck sold 1,000 shares of the business's stock in a transaction on Monday, October 16th. The shares were sold at an average price of $21.55, for a transaction totalling $21,550.00. Following the completion of the sale, the insider now directly owns 119,741 shares of the company's stock, valued at $2,580,418.55. Learn More on Craig Overpeck's trading history.
Who are Doximity's active insiders?: Doximity's insider roster includes Anna Bryson (CFO), Timothy Cabral (Director), Paul Jorgensen (CRO), Joseph Kleine (Insider), Gilbert Kliman (Director), Craig Overpeck (Insider), Kevin Spain (Director), and Kira Wampler (Director). Learn More on Doximity's active insiders.
Are insiders buying or selling shares of Doximity?: In the last twelve months, insiders at the sold shares 8 times. They sold a total of 34,214 shares worth more than $1,078,131.44. The most recent insider tranaction occured on April, 1st when Director Kira Scherer Wampler sold 2,500 shares worth more than $67,425.00. Insiders at Doximity own 39.4% of the company. Learn More about insider trades at Doximity.
Information on this page was last updated on 4/1/2024.

Craig Overpeck Insider Trading History at Doximity

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
10/16/2023	Sell	1,000	$21.55	$21,550.00	119,741
9/15/2023	Sell	1,000	$21.48	$21,480.00	120,741

Craig Overpeck Buying and Selling Activity at Doximity

Doximity Company Overview

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

Today's Range

Now: $23.82

$23.54

$24.10

50 Day Range

MA: $26.95

$23.59

$30.33

2 Week Range

Now: $23.82

$19.71

$36.92

Volume

874,526 shs

Average Volume

1,641,168 shs

Market Capitalization

$4.44 billion

P/E Ratio

36.09

Dividend Yield

N/A

Beta

1.17

His win rate puts Warren Buffett to shame…

From Investing Daily | Ad

Click here now for the full story.